0000950170-24-077850.txt : 20240626 0000950170-24-077850.hdr.sgml : 20240626 20240626160505 ACCESSION NUMBER: 0000950170-24-077850 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20240626 DATE AS OF CHANGE: 20240626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shuman Harry CENTRAL INDEX KEY: 0001791115 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37773 FILM NUMBER: 241073429 MAIL ADDRESS: STREET 1: C/O MERUS N.V. STREET 2: VALELAAN 62 CITY: UTRECHT STATE: P7 ZIP: 3584 CM ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merus N.V. CENTRAL INDEX KEY: 0001651311 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM BUSINESS PHONE: 31 030 253 8800 MAIL ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM FORMER COMPANY: FORMER CONFORMED NAME: Merus B.V. DATE OF NAME CHANGE: 20150819 5 1 ownership.xml 5 X0508 5 2022-12-31 0 1 0001651311 Merus N.V. MRUS 0001791115 Shuman Harry C/O MERUS N.V. UPPSALALAAN 17 UTRECHT P7 3584 CT NETHERLANDS false true false false VP Controller, PAO false Share Option (right to buy) 2022-02-14 4 A false 1000 0 A 2032-02-14 Common Stock 1000 1000 D Represents the exercise price of the options originally granted on February 14, 2022. Options vested over a one-year period from January 3, 2022. 50% vested on July 3, 2022 and the remaining vested in 6 equal monthly installments thereafter. This transaction reflects share options granted as part of a Company incentive program that were inadvertantly omitted in 2022. /s/ Peter Silverman as attorney-in-fact 2024-06-13